Latest Articles

Publication Date
MedEthix was recognized at the Healthcare Asia Pharma awards for its MedEthix Endometriosis Masterclass - Inquirer.net

MedEthix was recognized at the Healthcare Asia Pharma awards for its MedEthix Endometriosis Masterclass Inquirer.net

Published: July 29, 2025, 10:07 a.m.
UN Sustainable Development Goals Archives - Pharmafile

UN Sustainable Development Goals Archives Pharmafile

Published: July 29, 2025, 9:20 a.m.
The Salmon of Knowledge brings Irish charm to MediaCity with grand opening - I Love Manchester

The Salmon of Knowledge brings Irish charm to MediaCity with grand opening I Love Manchester

Published: July 28, 2025, 7:52 p.m.
Endometriosis Patient Information - Bedfordshire Hospitals NHS Foundation Trust

Endometriosis Patient Information Bedfordshire Hospitals NHS Foundation Trust

Published: July 28, 2025, 9:07 a.m.
Hair Relaxer Lawsuit Settlement | July 2025 Update - Lawsuit Information Center

Hair Relaxer Lawsuit Settlement | July 2025 Update Lawsuit Information Center

Published: July 27, 2025, 6:52 p.m.
'My boss has threatened to fire me if I take my prescription tablets at work' - Birmingham Live

'My boss has threatened to fire me if I take my prescription tablets at work' Birmingham Live

Published: July 27, 2025, 4:30 a.m.
James Whale reveals he’s struggling to breathe and talk in terminal cancer update - The Independent

James Whale reveals he’s struggling to breathe and talk in terminal cancer update The Independent

Published: July 25, 2025, 11:26 a.m.
SIENDO Study: Long-Term Safety and Efficacy of Selinexor Maintenance in Endometrial Cancer - OncLive

SIENDO Study: Long-Term Safety and Efficacy of Selinexor Maintenance in Endometrial Cancer OncLive

Published: July 24, 2025, 1:49 p.m.
Endometriosis Drugs Market Growing at Robust Expansion of the Decade: AbbVie, Pfizer, Astellas Pharma - openPR.com

Endometriosis Drugs Market Growing at Robust Expansion of the Decade: AbbVie, Pfizer, Astellas Pharma openPR.com

Published: July 24, 2025, 6:46 a.m.
Gesynta Pharma Adds $3.9M in Series B Funding for Endometriosis Drug, Total Round Reaches $31.5M - Femtech Insider

Gesynta Pharma Adds $3.9M in Series B Funding for Endometriosis Drug, Total Round Reaches $31.5M Femtech Insider

Published: July 23, 2025, 5:39 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!